Physician profile
Brian P Engebrecht
NPI 1629040191
$2,316.46
in general payments reported to CMS, 2019-2025
28 companies · $312 in 2025
The $312 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $954 · 2020: $487 · 2021: $161 · 2022: $403 · 2025: $312.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $312.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $311.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $406.29 | 2019-2022 | |
| Astellas Pharma US INC | $358.99 | 2019-2022 | |
| Janssen Biotech, INC. | $233.71 | 2019-2025 | Erleada |
| Teleflex LLC | $194.27 | 2021-2025 | Barrigel |
| Endo Pharmaceuticals INC. | $187.48 | 2019-2022 | |
| Procept Biorobotics Corporation | $136.43 | 2025 | |
| 180 Medical, INC. | $101.62 | 2019-2020 | |
| Calyxo, INC. | $90.77 | 2025 | Cvac Aspiration System |
| Coloplast Corp | $77.10 | 2020-2021 | |
| Therapeuticsmd, INC. | $43.80 | 2019 | |
| Dentsply Ih INC. | $41.39 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $41.14 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $39.44 | 2019-2020 | |
| Amgen INC. | $38.76 | 2019 | |
| Clovis Oncology, INC. | $36.97 | 2020 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $36.59 | 2022-2025 | |
| Dendreon Pharmaceuticals LLC | $36.15 | 2019 | |
| Boston Scientific Corporation | $34.60 | 2019 | |
| Antares Pharma, INC. | $29.98 | 2021-2022 | |
| Sun Pharmaceutical Industries INC. | $23.86 | 2019 | |
| Endo USA, INC. | $20.24 | 2025 | Xiaflex, Edex, Aveed |
| Blue Earth Diagnostics | $19.14 | 2019 | |
| Agiliti Surgical, INC. | $18.53 | 2019 | |
| Neotract INC. | $18.10 | 2020 | |
| Verity Pharmaceuticals INC. | $17.50 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $15.90 | 2022 | |
| Abbvie INC. | $13.30 | 2019 | |
| Travere Therapeutics, INC. | $4.41 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Engebrecht listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.